Oncology News

LAS VEGAS – Obesity was an independent risk factor for the development of colorectal cancer among patients who underwent weight loss surgery or who were on weight loss medication, according to a presentation.

FDA approvals of immunotherapies are among several exciting developments during the past couple of years in the field of upper gastrointestinal cancers, according to a speaker at Chemotherapy Foundation Symposium.

While colorectal adenocarcinoma incidence rates are increasing in white individuals aged 40 to 49 years, they are stabilizing in Black individuals of the same age, according to results published in JAMA Network Open.

The FDA granted fast track designation to TT-00420 for treatment of patients with cholangiocarcinoma who have no standard therapy options.

Healio Gastroenterology presents the following report on the top 10 peer-tested stories from the ACG Annual Scientific Meeting 2021.

LAS VEGAS — Multimodal circulating tumor DNA blood-based colorectal cancer screening tests may have clinically meaningful performance among patients in an average risk screening population, according to a presentation.

The addition of durvalumab to standard first-line chemotherapy extended survival among patients with advanced biliary tract cancer, according to topline data released by the agent’s manufacturer.

LAS VEGAS – Resiliency, respect and relationships allowed the ACG to thrive during the pandemic, pushed the careers of its leaders forward and brought the association back to in-person meetings.

LAS VEGAS – Prioritizing equity efforts and taking three key steps toward improving accessibility and representation could move the needle on health disparities in colon cancer screening, according to an ACG Postgraduate Course presentation.

This award goes to a product that stands out as a major disruption to the practice of gastroenterology.